iShares MSCI EAFE Growth ETF

Добавить в список отслеживания Добавить в список отслеживания
Добавить в портфель Добавить в портфель

Основные параметры

Цена последней сделки 100.92
Код ценной бумаги EFG
Полное наименование iShares MSCI EAFE Growth ETF
Объем 10406000000
Изм за день, % -0.0
Комиссия 0.39
Дата основания Aug 01. 2005
Ссылка ссылка
Тип актива Equity
Индекс MSCI EAFE Growth Index
Регион Developed Markets
Средний P/E 31.1
Дивиденды 0.85
5 летняя доходность 73.05
3 летняя доходность 33.45
Годовая доходность 26.91
Бета 0.79
Валюта usd
Топ 10 эмитентов, % 22.17
Количество компаний 438

Топ эмитентов

Эмитент Доля, % P/BV P/S P/E EV/Ebitda
Nestle 3.93
ASML Holding N.V. 3.12 18.39 13.7 80.92
Rogers Corporation 3 3.44 4.38 70.43 18.22
Moelis & Company 2.3 6.59 3.35 17.68
AstraZeneca PLC 1.66 8.13 4.8 39.72 20.95
Carlisle Companies 1.2 3.02 1.82 25.02 12.15
Osisko Gold Royalties Ltd 1.2 1.11 12.82 -26.09, Inc. 0.93 70.43 -464.71

Похожие ETF

Описание iShares MSCI EAFE Growth ETF

This ETF offers style-specific exposure to developed economies outside of North America, making EFG a potentially useful tool for investors looking to maintain a growth stock bias in their long-term portfolio or to put a tactical tilt on international equity exposure. By focusing on stocks that generally exhibit higher pricing multiples, lower dividend yields, and greater future growth potential, EFG offers targeted exposure to an asset sub-class that may perform well in certain environments. EFG is broad-based in nature, including hundreds of individual stocks across a number of different regions and more than a dozen countries. It should be noted, however, that there is some significant overlap between this fund and its value counterpart, EFV; these ETFs are based on indexes that use broad value and growth criteria, and as such the risk/return profile may be slightly different than expected. There are few alternatives for EAFE growth exposure, though those seeking to cast a wider net in this international equity space may prefer EFA, or better yet the low-cost VEA.